TIDMMSYS

Microsaic Systems plc

26 April 2017

26 April 2017

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Integration with SCPA chromatography software

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, is pleased to announce its collaboration with SCPA GmbH ("SCPA"), and the integration of Microsaic's 4000 MiD(R) compact mass spectrometer with SCPA's universal PrepCon 5 preparative data and control software.

The PrepCon 5 software can now be used in conjunction with the 4000 MiD(R) to control all functional aspects of the instrument's operation, including pumps, motor switch valves, autosamplers, detectors and fraction racks in any combination. In addition, the simple user interface allows the current status of the system to be monitored at any time.

Glenn Tracey, Microsaic's Chief Operating Officer, commented:

"The flexibility and modular structure of PrepCon 5 allows it to be adapted to any user's system. This universal capability enhances the usability of Microsaic's 4000 MiD(R) technology, particularly with non-specialist users, and appeals to the wider base of chemists wanting more deterministic approaches to their preparative work for chemical analyses."

SCPA (Software für Chromatographie und Prozess-Analytik), based near Bremen, Germany, is a developer of specialist software and hardware components needed for chromatography applications in research laboratories.

 
 Enquiries: 
 Microsaic Systems plc 
  Jim Ramage, CEO 
  Bevan Metcalf, FD               +44 (0) 1483 751577 
 N+1 Singer (Nominated Adviser 
  & Broker) 
  Shaun Dobson 
  Liz Yong                        +44 (0)20 7496 3000 
 Citigate Dewe Rogerson 
  (Financial PR) 
  Mark Swallow 
  Marine Perrier                  +44 (0)20 7638 9571 
 

About Microsaic Systems

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

The Microsaic 4000 MiD(R), single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

www.microsaic.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAOKPDKABKDDQB

(END) Dow Jones Newswires

April 26, 2017 02:01 ET (06:01 GMT)